Results for:(84 found)
Oct 18, 2012 11:43AM on Top StocksBy Stock Traders Daily

Although Abbott has recently gained on positive trial results, Gilead Sciences remains in the forefront of the market.

Oct 17, 2012 5:25PM on Top StocksBy Jim J. Jubak

Both companies want to develop a replacement to the standard year-long injection treatment.

Oct 2, 2012 11:28AM on Top StocksBy TheStreet Staff

The company's Abraxane delays tumor growth in patients with advanced melanoma.

Sep 21, 2012 10:34AM on Top StocksBy TheStockAdvisors

The drug company is a defensive, income generator with added potential for capital gains.

Tags: AZNBMY
Sep 11, 2012 11:09AM on Top StocksBy MSN Money Partner

Bristol-Myers Squibb is upgraded to 'conviction buy' at Goldman, and Yelp is initiated with a 'neutral' at Piper Jaffray.

Aug 29, 2012 9:45AM on Top StocksBy Jim Cramer

Despite the current gloom, the market is in a heck of a better place than it was 12 months ago.

Aug 28, 2012 2:45PM on Top StocksBy Minyanville.com

The US approval of Stribild is a big plus for the company's AIDS treatment franchise.

Aug 24, 2012 11:17AM on Top StocksBy MSN Money Partner

Autodesk is downgraded at 2 firms, and General Growth is downgraded to 'neutral.'

VIDEO ON MSN MONEY

DATA PROVIDERS

Copyright © 2014 Microsoft. All rights reserved.

Fundamental company data and historical chart data provided by Morningstar Inc. Real-time index quotes and delayed quotes supplied by Morningstar Inc. Quotes delayed by up to 15 minutes, except where indicated otherwise. Fund summary, fund performance and dividend data provided by Morningstar Inc. Analyst recommendations provided by Zacks Investment Research. StockScouter data provided by Verus Analytics. IPO data provided by Hoover's Inc. Index membership data provided by Morningstar Inc.